493 results on '"Lechtzin, Noah"'
Search Results
2. Maternal and fetal outcomes in multiparous women with Cystic Fibrosis
3. Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force
4. Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
5. The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis
6. Telemedicine and remote monitoring in cystic fibrosis
7. Indoor air pollution exposure is associated with greater morbidity in cystic fibrosis
8. Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: A mixed methods study
9. A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis
10. Health care costs related to home spirometry in the eICE randomized trial
11. Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations
12. The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis
13. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
14. Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression
15. Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis
16. Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis
17. Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis
18. Descriptions of the Pain Experience in Adults and Adolescents with Cystic Fibrosis
19. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis
20. COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
21. The Association Between Pain and Clinical Outcomes in Adolescents With Cystic Fibrosis
22. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS
23. Snap, Crackle, and Pop: From a Painful Finger to Progressive Dyspnea to Popping Neck Pain
24. Courage-als: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
25. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis
26. MiToS and King’s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial
27. Prevalence and Risk Factors for Low Bone Mineral Density in Adults With Cystic Fibrosis
28. Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results
29. An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor
30. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
31. Associations of Sputum Biomarkers with Clinical Outcomes in People with Cystic Fibrosis
32. Viruses to the rescue—Use of bacteriophage to treat resistant pulmonary infections
33. Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding
34. Primary Cytomegalovirus Phosphoprotein 65—Specific CD8⁺ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients
35. Pain Is a Common Problem Affecting Clinical Outcomes in Adults With Cystic Fibrosis
36. Appropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis
37. The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases
38. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
39. Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy
40. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
41. Vitamin D Deficiency Is Associated with Increased Nontuberculous Mycobacteria Risk in Cystic Fibrosis
42. Association between respiratory tract methicillin-resistant staphylococcus aureus and survival in cystic fibrosis
43. Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial.
44. Optimizing Endobronchial Ultrasound for Molecular Analysis. How Many Passes Are Needed?
45. Coronary flow reserve correlates with right ventricular dysfunction and predicts right heart failure in patients with pulmonary arterial hypertension
46. The PROSPECT Is Bright for CFTR Modulators
47. Safety and Feasibility of Interventional Pulmonologists Performing Bedside Percutaneous Endoscopic Gastrostomy Tube Placement
48. Validation of the Cough Quality-of-Life Questionnaire in Patients With Idiopathic Pulmonary Fibrosis
49. Comparison of 21-Gauge and 22-Gauge Aspiration Needle in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Results of the American College of Chest Physicians Quality Improvement Registry, Education, and Evaluation Registry
50. Training Perspective. The Impact of Starting an Endobronchial Ultrasound Program at a Major Academic Center on Fellows Training of Transbronchial Needle Aspiration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.